Similar Posts
Ahead of Market: 10 things that will decide stock market action on Wednesday
Nifty’s final session of FY26 ended in the deep red, settling 5% lower in the financial year ended March 31, 2026 while the BSE Sensex plunged 7% in the same period. The 50-stock index fell 2% on Monday to close at 22,331.40, recording its second successive fall, dragged by a sell-off across sectors. Heavyweight sectors…
Just Released: 5 Top Motley Fool Stocks to Buy in April 2026
Premium content from Motley Fool Stock Advisor Canada Volatility continues, which is something we welcome with open arms when it comes to putting together this monthly collection of our five favourite stocks to buy now. Because, if there’s a theme to pull through this month’s group, it’s that all these stocks are cheaper than they…
Ahead of Market: 10 things that will decide stock action on Thursday
Domestic headline equity indices ended lower on Wednesday as investors booked profits across sectors, ahead of key U.S. inflation data that could influence the size of a likely reduction in Federal Reserve interest rates next week. The Nifty 50 index fell 0.49% to 24,918, while the S&P BSE Sensex lost 0.49% to 81,523. Here’s how…
AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
AbbVie NYSE: ABBV was among the pharma companies worst positioned for a patent cliff that has come and gone. However, management’s lean toward diversifying away from Humira and into a broader range of treatments has more than paid off. The takeaway is that growth is back in the immunology portfolio despite the 30% contraction in…
DPST: Euphoria Turns To Dispair In A Mere 6 Months (NYSEARCA:DPST)
DPST: Euphoria Turns To Despair In A Mere 6 Months Source link
